, Tracking Stock Market Picks
Enter Symbol:
Gilead Sciences, Inc. (GILD) [hlAlert]

up 453.22 %

Gilead Sciences, Inc. (GILD) rated Buy with price target $125 by Deutsche Bank

Posted on: Tuesday,  Dec 23, 2014  12:25 PM ET by Deutsche Bank

Deutsche Bank rated Buy Gilead Sciences, Inc. (NASDAQ: GILD) on 12/23/2014. Previously Deutsche Bank rated Buy Gilead Sciences, Inc. (NASDAQ: GILD) on
04/21/2011., when the stock price was $19.52. Since then, Gilead Sciences, Inc. has gained 453.23% as of 10/28/2015's recent price of $107.99.
If you would have followed the previous Deutsche Bank's recommendation on GILD, you would have gained 453.22% of your investment in 1651 days.

Gilead Sciences, Inc. (Gilead) is a biopharmaceutical company that discovers, develops, and commercializes therapeutics in areas of unmet medical need. The Company has United States and international commercial sales operations, with marketing subsidiaries in Australia, Austria, Canada, France, Germany, Greece, Ireland, Italy, New Zealand, Portugal, Spain, Switzerland, Turkey, United Kingdom, and United States. Its commercial team promotes Truvada, Viread, Emtriva, Hepsera, AmBisome, Letairis, and Flolan through direct field contact with physicians, hospitals, clinics, and other healthcare providers. Gilead?s corporate partner, Astellas Pharma, Inc. (Astellas), promotes and sells AmBisome in the United States, Canada, Europe, Australia, and New Zealand. In May 2008, the Company acquired Navitas Assets, LLC?s. In April 2009, the Company announced the completion of its acquisition of CV Therapeutics, Inc.

Deutsche Bank is one of the largest European fund managers. DWS was founded in 1956 and is an integral part of the Asset Management division of Deutsche Bank. This division is one of the largest global asset managers.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/23/2014 12:25 PM Buy
88.09 125.00
as of 10/17/2014
1 Week down  -2.87 %
1 Month down  -2.97 %
3 Months up  18.43 %
1 YTD up  34.15 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/28/2014 1:25 PM Buy
80.72 132.00
4/16/2013 1:25 PM Buy
51.85 69.00
11/13/2012 12:25 PM Buy
36.84 47.50
8/16/2011 1:25 PM Buy
19.16 26.50
4/21/2011 12:25 PM Buy
19.52 22.50

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy